In medical devices and regulated health tech, no change is isolated. Modifying a single passive electronic component or adjusting an embedded sensor sampling loop ripples outward across risk analyses, verification protocols, clinical safety endpoints, and global market clearances. PMX Change Intelligence automatically simulates complete transitive blast radiuses in milliseconds.
Subject: Replacing Primary Analog Core Temperature Sensor (S-18) with Digital Low-Power Transducer (S-22) on CardioSense Pro v3.8.2.
Granular list of downstream design controls invalidated by the S-18 → S-22 transition.
| Domain | Object ID | Name / Description | Impact Nature | Required Regulatory Action |
|---|---|---|---|---|
| Requirement | REQ-0184 |
Surface Thermal Limit (<41.0°C) | Thermal dissipation delta (+0.3W peak) | Re-verify boundary limit test |
| Requirement | REQ-0190 |
ADC Sampling Frequency | Shift from 10-bit analog to 16-bit I2C digital | Software sensor driver update |
| Risk | RSK-0044 |
Cutaneous Thermal Erythema | Thermal gradient shifts towards chassis corner | FMEA severity/occurrence re-score |
| Risk | RSK-0051 |
Sensor Calibration Drift over 36h | Silicon drift profile differs from NTC thermistor | Add self-calibration firmware sanity check |
| Verification | V-0183 |
36h Continuous Thermal Stress Bench Test | Prior bench test invalidated by sensor switch | Re-run 36-hour protocol under PROTO-TH-902 |
| Verification | V-0201 |
EMC Radiated Immunity (IEC 60601-1-2) | New digital I2C bus adds 400kHz EMI clock harmonics | Re-test anechoic chamber immunity |
| Regulatory | 510(k) K240982 |
FDA Premarket Notification Technical Summary | Sensor comparison to predicate device altered | Evaluate 510(k) modification decision tree |
| Regulatory | MDR-ANNEX-II |
EU MDR Technical Documentation Section 4.2 | Substantial design change notification threshold | Notify Notified Body 0123 (TÜV SÜD) |
| Cybersecurity | SEC-CTRL-19 |
I2C Bus Inter-Chip Telemetry Spoofing | Digital communication introduces bus injection vector | Implement SHA-256 bus packet checksum |
| Clinical | CLN-088 |
Clinical Investigation Safety Endpoint | Skin irritation rate must match trial cohort CS-088 | Update Clinical Evaluation Report (CER) |
| Supplier | SUP-ALPHA |
OmniSem Semiconductor Tier-1 Qualification | New silicon vendor must be audited into ASL | Execute ISO 13485 supplier audit QS-511 |
In consumer electronics, a hardware ECO costs thousands of dollars and takes days. In medical devices, an unvetted ECO costs upwards of $350,000 and causes catastrophic regulatory delays.
When a downstream verification omission is caught late in submission review by the FDA or an EU Notified Body, the average cost of halting production, re-running biological/EMC tests, and filing formal supplements exceeds $380k.
A missed risk mitigation or an outdated test protocol that fails an ISO 13485 audit halts global distribution. In competitive therapeutic markets, a 7-month delay represents millions in lost market exclusivity and physician adoption.
Instead of 4 weeks of cross-functional alignment meetings, engineers and regulatory affairs directors generate exhaustive, mathematically verified impact assessments in less than 3 minutes, ready for Design Review Committee sign-off.
Caught via PMX Knowledge Graph before schematic release. Instant model recalculation.
Caught during automated protocol execution. Requires localized PCB re-spin and bench re-test.
Deficiency letter received from FDA or Notified Body. Halts regulatory clock for 90 days.
Unintended thermal injury occurs in clinical practice. FDA Class II recall + legal liabilities.
PMX Change Intelligence does not rely on simple keyword matches. It models the actual physical, logical, biological, and jurisdictional semantics of your product.
When replacing Sensor S-18 with S-22, PMX scans the active Bill of Materials (BOM Rev J), component footprints, PCB traces, voltage regulator current budgets, and I2C address conflicts. It automatically flags that S-22 requires an additional 3.3V decoupling capacitor and adjusts power budget calculations for 36-hour battery life.
Traverses the risk graph to detect how changes shift fault probabilities. S-22 has a higher peak thermal burst during calibration, altering RSK-0044 (Thermal Injury). The system forces the FMEA record into Suspect state, requiring the Risk Manager to evaluate whether residual risk remains acceptable under ALARP policies.
PMX inspects test evidence hashes. Protocol V-0183 (36h thermal stress) was executed on S-18 Rev D. Because S-22 alters thermodynamic thermal resistance, V-0183's evidence token is flagged as expired. The system automatically drafts a new execution protocol shell with identical boundary parameters and sample size justifications.
Evaluates the change against the FDA's "Deciding When to Submit a 510(k) for a Software/Hardware Change" guidance. Determines that while fundamental scientific technology is unchanged, thermal safety profile changes require an internal Letter to File (LtF-2026-08) and an update to the EU MDR Annex II technical dossier for Notified Body 0123.
Examines whether sensor substitution degrades clinical accuracy claims. CardioSense Pro's core claim (±0.1°C clinical temperature accuracy validated in trial CLN-088) is evaluated against S-22's published sensor tolerance curve to confirm that statistical confidence intervals remain valid without requiring a new clinical investigation.
S-22 is manufactured by OmniSem Corp, currently classified as Tier-2 in the Approved Supplier List (ASL). PMX generates a supplier qualification task requiring an on-site ISO 13485 quality system audit and Certificate of Analysis (CoA) verification before production release.
Because S-22 contains on-die programmable EEPROM registers over an open I2C bus, PMX triggers FDA Section 524B medical device cybersecurity controls. It adds a requirement for cryptographic bus authentication (SEC-CTRL-19) to prevent hardware-level telemetry spoofing attacks.
Changes to the component package require updating surface-mount technology (SMT) pick-and-place nozzles, reflow solder thermal profiles, and production line End-of-Line (EOL) functional automated test fixtures, flagging an IQ/OQ/PQ re-validation protocol.
Compare the conventional disconnected enterprise change review with PMX automated graph propagation.
| Workflow Dimension | Traditional Manual ECO Process | PMX Continuous Change Intelligence |
|---|---|---|
| Scoping Duration | 3 to 5 Weeks — requires scheduling cross-functional meetings across 6 departments. | Under 3 Seconds — graph traversal evaluates full transitive closure instantly. |
| Dependency Discovery | Human memory, tribal knowledge, and keyword searching across SharePoint folders. Misses 20-30% of second-order dependencies. | Ontological graph propagation guarantees 100% transitive edge traversal across all 8 domains. |
| Regulatory Determination | Regulatory Affairs spends 10 days reviewing static FDA guidance documents to write an impact justification memo. | Automated decision tree analysis cross-references FDA 510(k) and EU MDR Article 120 thresholds with verified rationale. |
| Traceability Auditability | Disconnected spreadsheets that desynchronize within 48 hours of approval. High audit vulnerability. | Every impact decision, cryptographic signature, and rationale is stored in an immutable 21 CFR Part 11 audit ledger. |
| Human Authority Role | Engineers spend 80% of their time gathering data and 20% making decisions. | Zero data gathering required. Authorities focus 100% of their time reviewing AI proposals and providing critical sign-offs. |
Integrate PMX Change Intelligence into your active engineering pipeline. See every impacted requirement, risk, and regulatory filing before executing an ECO.